If you or a loved one took Dupixent and later developed cancer, specifically T-Cell Lymphoma, you may be eligible for compensation.
Dupixent is a powerful biologic medicine that was widely prescribed for atopic dermatitis, asthma, and other common inflammatory conditions. Unfortunately, recent research suggests the drug may carry a risk of severe harm to patients, including the development of rare cancers in people who used it.
At Friedman Law Offices, our Nebraska dangerous drug lawyers are investigating and building Dupixent claims right now. We can help you determine if you may be entitled to compensation for your medical bills, lost income, pain and suffering, and other damages. Call or contact us today for a free, no-obligation case review.
What Is Dupixent?
Dupixent is the brand name for the monoclonal antibody dupilumab, which is developed and manufactured by Sanofi and Regeneron Pharmaceuticals. It’s designed to treat eight different conditions, including:
- Asthma
- Bullous Pemphigoid
- Chronic Obstructive Pulmonary Disease
- Chronic Rhinosinusitis With Nasal Polyps
- Chronic Spontaneous Urticaria
- Eczema/Atopic Dermatitis
- Eosinophilic Esophagitis
- Prurigo Nodularis
It works to treat these conditions by blocking the interleukin-4 receptor alpha (IL-4Rα) and inhibiting IL-4 and IL-13 signaling, which are two key drivers of type-2 inflammation. Because Dupixent offered a new, highly targeted approach to inflammatory diseases compared to older medications, its use became widespread.
Patients who previously suffered many of the conditions listed above were prescribed Dupixent in hopes of improving their quality of life. Unfortunately, some of those patients have now been diagnosed with rare forms of cancer.
How Can Dupixent Harm People Who Take It?
Growing medical and legal evidence indicates Dupixent may carry serious risks, including the possibility of triggering or accelerating certain cancers.
- In a retrospective analysis, users of dupilumab (the active molecule in Dupixent) diagnosed with atopic dermatitis were found to have a significantly elevated relative risk of developing Cutaneous T‑Cell Lymphoma (CTCL) compared to non-users.
- Data also reveal serious adverse events (including hospitalizations and deaths) in patients using Dupixent, with some reports pointing to injection-site reactions, anaphylaxis, eosinophilia, or other immune-related complications.
- A 2024 study warns that although dupilumab is “safe for most patients,” several patients with CTCL had unfavorable outcomes during treatment.
If you took Dupixent and later developed skin lesions, persistent rash changes, enlarged lymph nodes, nodules, unexplained fatigue or other signs of lymphoma, especially CTCL, you may have suffered a serious injury linked to the medication. Because CTCL is often misdiagnosed early on, physicians and patients need to be alert to changes after treatment with Dupixent begins.
What Compensation Can I Receive for a Dupixent-Related Injury?
If you suffered harm after taking Dupixent, you may be eligible to recover damages in several categories:
- Medical Expenses: We’ll work hard to help you get compensation for past and future costs of treating your condition, including hospitalizations, surgeries, oncology care, monitoring, medications, and rehabilitation.
- Lost Wages or Lost Earning Capacity: If your injury forced you to miss work, change jobs, or diminished your ability to earn in the future, you may claim for lost income.
- Pain and Suffering: Pain and suffering damages can include compensation for emotional distress, diminished quality of life, and anxiety over a cancer diagnosis and its related complications.
- Wrongful Death: In fatal cases linked to the drug, families may bring wrongful death claims against its manufacturer for funeral costs, loss of companionship, and survival damages.
Your specific compensation will depend on the strength of your medical evidence, timing of drug exposure, severity of injury, and how the injury impacts your life moving forward. At Friedman Law Offices, we evaluate all of these factors to seek the maximum available recovery.
How Friedman Law Offices Help With Your Dupixent Claim
At Friedman Law Offices, we bring the experience, resources, and client-first focus you need when challenging major pharmaceutical companies with potentially dangerous drugs on the market.
With our firm on your side, we promise to:
- Conduct a Deep Investigation: We will obtain your medical records, prescription history, and treatment timeline to establish how Dupixent may have caused or contributed to your injury.
- Collaborate With Experts: We retain medical-scientific experts (dermatology, oncology, immunology) to analyze the connection between Dupixent and your condition.
- Manage Your Case: Our firm handles these claims from start to finish, and we keep you informed every step of the way.
- Work at No Upfront Cost: We work on a contingency basis. That means you pay us nothing unless we recover for you.
- Advocate For You and Your Family: Defective drug litigation is a core part of our work, which means you get dedicated attention from attorneys well-versed in pharmaceutical company liability.
- Work Quickly and Efficiently: The clock may be ticking on your case. Prescription-drug claims have deadlines, and gathering evidence early strengthens your position and chances of recovering full compensation.
Contact Our Nebraska Dupixent Injury Lawyers Today
If you used Dupixent and were diagnosed with cutaneous T-cell lymphoma or another type of cancer, don’t wait. You deserve answers, accountability, and the chance to hold the manufacturer responsible.
Call or fill out our confidential online form to schedule your free initial review with Friedman Law Offices. There’s no obligation or upfront fee to take this first step toward justice and compensation. Our clients count on us to fight for them. Now, let us fight for you by contacting us today.